Format

Send to:

Choose Destination
See comment in PubMed Commons below
Int Clin Psychopharmacol. 1999 Sep;14(5):283-5.

Lithium versus carbamazepine in the maintenance treatment of bipolar II disorder and bipolar disorder not otherwise specified.

Author information

  • 1Psychiatric Hospital, University of Munich, Germany. wgreil@psy.med.uni-muenchen.de

Abstract

In a randomized clinical trial (MAP study), the prophylactic efficacy of lithium and carbamazepine was compared in a subgroup of patients (n = 57) who presented either a bipolar II disorder or a bipolar disorder not otherwise specified (DSM-IV). During the observation period of 2.5 years, no significant differences between the drugs were found considering hospitalization, recurrences, subclinical recurrences, concomitant medication and severe side-effects.

PMID:
10529071
[PubMed - indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Loading ...
    Write to the Help Desk